Image: StatnewsThree biotechs with three news updates
• Gilead Sciences has successfully won a legal case regarding its HIV medication, securing a favorable ruling for the company. • Eli Lilly announced plans to expand patient access to retatrutide, a promising weight-loss and metabolic drug currently in development. • These updates highlight critical legal and clinical milestones for major pharmaceutical players in the HIV and obesity treatment markets.
statnews.com




